Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/14683
Title: Egr2 and 3 Inhibit T-bet-Mediated IFN-γ Production in T Cells.
Authors: Singh, R
Miao, T
Symonds, AL
Omodho, B
Li, S
Wang, P
Issue Date: 22-May-2017
Publisher: American Association of Immunologists
Citation: Singh R, Miao T, Symonds AL, Omodho B, Li S, Wang P. Egr2 and 3 Inhibit T-bet–Mediated IFN-γ Production in T Cells. The Journal of Immunology. 2017 Jun 1;198(11):4394-402.
Abstract: T-bet is important for differentiation of cytotoxic CD8 and Th1 CD4 T cells. We have discovered that Egr2 and 3 are potent inhibitors of T-bet function in CD4 and CD8 effector T cells. Egr2 and 3 were essential to suppress Th1 differentiation in Th2 and Th17 conditions in vitro and also to control IFN-g–producing CD4 and CD8 T cells in response to virus infection. Together with Egr2 and 3, T-bet is induced in naive T cells by Ag stimulation, but Egr2 and 3 expression was inhibited by Th1–inducing cytokines. We found that Egr2 and 3 physically interact with the T-box domain of T-bet, blocking T-bet DNA binding and inhibiting T-bet–mediated production of IFN-g. Thus, Egr2 and 3 are antagonists of T-bet function in effector T cells and are important for the control of inflammatory responses of T cells. The Journal of Immunology, 2017, 198: 000–000.
URI: http://bura.brunel.ac.uk/handle/2438/14683
DOI: http://dx.doi.org/10.4049/jimmunol.1602010.
ISSN: 0022-1767
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf2.22 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.